MNKs are a group of kinases that interact with MAPKs, particularly ERK and p38, to regulate protein synthesis by phosphorylating the eukaryotic initiation factor 4E (eIF4E). MNK signaling plays a role in cellular stress responses, inflammation, and cancer progression. Targeting MNKs is an emerging strategy in cancer therapy and anti-inflammatory treatments. At CymitQuimica, we provide a selection of MNK inhibitors and modulators to support your research in protein synthesis regulation, oncology, and inflammation.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.